China Jo-Jo Drugstores (CJJD) has a profit margin of -3.6%, below the Healthcare sector average of 9.48%.
Get informed when a big investor buys or sells
+ FollowAs of May 2026
Trailing 12 months ending May 2026
The latest profit margin for CJJD is -3.6% as of May 2026. That compares with -13.88% in the prior-year period — up 74.0% year over year. That is below the Healthcare sector average of 9.48%. Investors often review this figure alongside China Jo-Jo Drugstores's historical trend and sector peers before judging valuation or financial health.
Over the past year, CJJD's profit margin moved from -13.88% to -3.6% — a 74.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in China Jo-Jo Drugstores's valuation or profitability profile.
Against Healthcare companies, CJJD currently prints -3.6% for profit margin, while the sector average sits near 9.48%. That is roughly 138.0% below the sector mean. Large gaps often invite a closer look at China Jo-Jo Drugstores's growth, margins, and balance sheet.
Profit Margin shows how effectively China Jo-Jo Drugstores converts resources into returns. At -3.6%, CJJD may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -13.88% in the prior-year period — up 74.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting CJJD's profit margin (-3.6%), review year-over-year change from -13.88%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.